FY2026 EPS Estimates for Senseonics Lifted by HC Wainwright

Senseonics Holdings, Inc. (NYSE:SENS - Free Report) - HC Wainwright raised their FY2026 EPS estimates for Senseonics in a report released on Tuesday, July 8th. HC Wainwright analyst S. Lee now forecasts that the company will post earnings of ($0.05) per share for the year, up from their previous forecast of ($0.06). HC Wainwright currently has a "Buy" rating and a $1.40 target price on the stock. The consensus estimate for Senseonics' current full-year earnings is ($0.14) per share.

Other equities research analysts also recently issued reports about the stock. Mizuho initiated coverage on shares of Senseonics in a research report on Thursday, April 10th. They set an "outperform" rating and a $2.00 target price for the company. Wall Street Zen upgraded shares of Senseonics to a "sell" rating in a report on Monday, May 12th.

Senseonics Stock Up 1.4%

Shares of NYSE:SENS traded up $0.01 during midday trading on Thursday, hitting $0.50. 4,416,829 shares of the company's stock were exchanged, compared to its average volume of 7,156,545. The company has a debt-to-equity ratio of 59.17, a current ratio of 2.47 and a quick ratio of 2.38. The stock has a 50 day moving average price of $0.54 and a 200-day moving average price of $0.68. The company has a market cap of $327.11 million, a PE ratio of -3.85 and a beta of 0.92. Senseonics has a 12 month low of $0.25 and a 12 month high of $1.40.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in SENS. Raymond James Financial Inc. purchased a new position in Senseonics in the fourth quarter valued at about $26,000. IFP Advisors Inc boosted its stake in Senseonics by 120.9% in the first quarter. IFP Advisors Inc now owns 47,500 shares of the company's stock valued at $31,000 after acquiring an additional 26,000 shares during the last quarter. CTC Alternative Strategies Ltd. purchased a new position in Senseonics in the first quarter valued at about $31,000. HighTower Advisors LLC purchased a new position in Senseonics in the fourth quarter valued at about $32,000. Finally, Two Sigma Investments LP bought a new stake in shares of Senseonics in the fourth quarter valued at approximately $36,000. 12.36% of the stock is currently owned by hedge funds and other institutional investors.

Senseonics Company Profile

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.